Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta Health SCOTTSDALE, AZ, UNITED STATES, March 19 ...
In a randomized phase 3 trial, adding tumor debulking to first-line chemotherapy did not significantly improve overall survival or progression-free survival (PFS) and was associated with an increased ...
Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer: Results From the Randomized ...
In patients with oligometastatic prostate cancer, metastasis-directed therapy plus standard of care was associated with significant improvements in progression-free survival (PFS), radiographic PFS, ...
“Modern system-on-chips (SoCs) are becoming prone to numerous security vulnerabilities due to their ever-growing complexity and size. Therefore, a comprehensive security verification framework is ...
DUBLIN, Jan. 6, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab ...
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA) has announced the completion of targeted full enrolment of 435 patients in its OptimuUM-02 Phase 2/3 trial, evaluating Darovasertib in combination with ...
Perplexity’s live retrieval makes its citations look more like Google’s search results. ChatGPT and Gemini rely more on selective, model-driven choices than on current rankings. Google visibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results